Zoar Limited Completes Business Combination; FY26 Revenue Rose 17.1%
Zoar completed its business combination with Impact Biomedical and acquired Zoar Labs. Zoar Labs reported FY2026 revenue of $651.7M versus $556.4M and net income of $77.7M versus $62.7M in the prior fiscal year.Material DetailsContext by AI AnalystThis is a transaction-completion and listing milest…